Evidence map›Paper›PMID 41403644›Full record

ReviewFrontiers in microbiology2025

Integrated PRRSV prevention and control strategy based on the One Health concept: across the boundaries of virology, ecology and public health.

Hongbo Chen, Chengzhen Weng, Xinxin Huang, Xiaobing Li, Dianning Duan

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongbo ChenCollege of Life Sciences, Longyan University, Longyan, Fujian, China.
Chengzhen WengCollege of Life Sciences, Longyan University, Longyan, Fujian, China.
Xinxin HuangCollege of Life Sciences, Longyan University, Longyan, Fujian, China.
Xiaobing LiCollege of Life Sciences, Longyan University, Longyan, Fujian, China.
Dianning DuanCollege of Life Sciences, Longyan University, Longyan, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) poses a major threat to global swine production, with substantial economic losses and serious animal welfare concerns. Although PRRSV is not considered a zoonotic agent, its control exemplifies the necessity of a One Health approach, incorporating virological, ecological, immunological, and agricultural dimensions. This article contends that the impact of PRRSV extends beyond porcine populations, significantly contributing to the emergence of antimicrobial resistance (AMR) via secondary bacterial infections and the consequent misuse of antibiotics. Moreover, the environmental persistence of the virus and its potential for indirect transmission raise critical ecological questions that remain unresolved. By synthesizing current evidence, this review delineates the complex interrelationships among PRRSV outbreaks, patterns of antimicrobial use, and environmental contamination. This study propose an integrated One Health framework for PRRSV surveillance and control, emphasizing the implementation of genomic tools, systematic environmental monitoring, and enhanced collaboration among public health, veterinary, and environmental sectors. Integrating these disciplines is crucial to alleviating the multidimensional challenges posed by PRRSV, thereby protecting animal welfare, supporting sustainable agriculture, and strengthening global public health.

Indexed as

antimicrobial resistanceenvironmental monitoringintegrated control strategyOne HealthPorcine Reproductive and Respiratory Syndrome Virus

Identifiers

PMID41403644
PMCPMC12702985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.